Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Denton

Showing results (61-70 of 484) with videos related to

Pageof 49
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|November 10, 2017
Editorial: Bench to Bedside-and Back Again: Finding the Goldilocks Zone Within the Scleroderma UniverseJanet E Pope, Jason J Lee, Christopher P Denton
Arthritis & Rheumatology (Hoboken, N.J.)|May 8, 2025
Reply to: Circulating interferon alpha protein measured with digital ELISA as a biomarker for modified Rodnan skin score progression in limited systemic sclerosis: comment on the article from Di Donato et alStefano Di Donato, Christopher P Denton, Francesco Del Galdo
Nature Reviews. Rheumatology|October 15, 2018
Author Correction: Major lung complications of systemic sclerosisChristopher P Denton, Athol U Wells, John G Coghlan
Annals of the New York Academy of Sciences|October 4, 2007
Treatment of autoimmune disease with rabbit anti-T lymphocyte globulin: clinical efficacy and potential mechanisms of actionSimon D Lytton, Christopher P Denton, Achim M Nutzenberger
Best Practice & Research. Clinical Rheumatology|March 10, 2020
Scleroderma mimics - Clinical features and managementCatherine H Orteu, Voon H Ong, Christopher P Denton
Current Opinion in Rheumatology|September 5, 2009
Animal models of scleroderma: lessons from transgenic and knockout miceEmma C Derrett-Smith, Christopher P Denton, Sonali Sonnylal
Clinical and Experimental Rheumatology|April 19, 2014
Current management strategies for systemic sclerosisSvetlana I Nihtyanova, Voon H Ong, Christopher P Denton
Rheumatic Diseases Clinics of North America|April 7, 2023
The Exciting Future for Scleroderma: What Therapeutic Pathways Are on the Horizon?Jörg H W Distler, Gabriela Riemekasten, Christopher P Denton
Arthritis & Rheumatology (Hoboken, N.J.)|April 10, 2025
ReplyStefano Di Donato, Christopher P Denton, Francesco Del Galdo
Seminars in Respiratory and Critical Care Medicine|May 29, 2019
Multidisciplinary Evaluation in Patients with Lung Disease Associated with Connective Tissue DiseaseAthol Wells, Anand Devaraj, Elizabetta A Renzoni, et al.
Pageof 49

Showing results (61-70 of 484) with videos related to

Sort By:
Pageof 49
Arthritis & Rheumatology (Hoboken, N.J.)|November 10, 2017
Editorial: Bench to Bedside-and Back Again: Finding the Goldilocks Zone Within the Scleroderma UniverseJanet E Pope, Jason J Lee, Christopher P Denton
Arthritis & Rheumatology (Hoboken, N.J.)|May 8, 2025
Reply to: Circulating interferon alpha protein measured with digital ELISA as a biomarker for modified Rodnan skin score progression in limited systemic sclerosis: comment on the article from Di Donato et alStefano Di Donato, Christopher P Denton, Francesco Del Galdo
Nature Reviews. Rheumatology|October 15, 2018
Author Correction: Major lung complications of systemic sclerosisChristopher P Denton, Athol U Wells, John G Coghlan
Annals of the New York Academy of Sciences|October 4, 2007
Treatment of autoimmune disease with rabbit anti-T lymphocyte globulin: clinical efficacy and potential mechanisms of actionSimon D Lytton, Christopher P Denton, Achim M Nutzenberger
Best Practice & Research. Clinical Rheumatology|March 10, 2020
Scleroderma mimics - Clinical features and managementCatherine H Orteu, Voon H Ong, Christopher P Denton
Current Opinion in Rheumatology|September 5, 2009
Animal models of scleroderma: lessons from transgenic and knockout miceEmma C Derrett-Smith, Christopher P Denton, Sonali Sonnylal
Clinical and Experimental Rheumatology|April 19, 2014
Current management strategies for systemic sclerosisSvetlana I Nihtyanova, Voon H Ong, Christopher P Denton
Rheumatic Diseases Clinics of North America|April 7, 2023
The Exciting Future for Scleroderma: What Therapeutic Pathways Are on the Horizon?Jörg H W Distler, Gabriela Riemekasten, Christopher P Denton
Arthritis & Rheumatology (Hoboken, N.J.)|April 10, 2025
ReplyStefano Di Donato, Christopher P Denton, Francesco Del Galdo
Seminars in Respiratory and Critical Care Medicine|May 29, 2019
Multidisciplinary Evaluation in Patients with Lung Disease Associated with Connective Tissue DiseaseAthol Wells, Anand Devaraj, Elizabetta A Renzoni, et al.
Pageof 49